These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7074181

  • 1. Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment.
    van Kammen DP, Docherty JP, Bunney WE.
    Biol Psychiatry; 1982 Feb; 17(2):233-42. PubMed ID: 7074181
    [Abstract] [Full Text] [Related]

  • 2. Lack of behavioral supersensitivity to d-amphetamine after pimozide withdrawal. A trial with schizophrenic patients.
    van Kammen DP, Docherty JP, Marder SR, Schulz SC, Bunney WE.
    Arch Gen Psychiatry; 1980 Mar; 37(3):287-90. PubMed ID: 6102456
    [Abstract] [Full Text] [Related]

  • 3. Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine response.
    van Kammen DP, Docherty JP, Marder SR, Schulz SC, Dalton L, Bunney WE.
    Arch Gen Psychiatry; 1982 Mar; 39(3):261-6. PubMed ID: 7065839
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Dose-effect relations. Doubleblind study on two different doses of pimozide (author's transl)].
    Fleischhauer J.
    Arzneimittelforschung; 1978 Mar; 28(9):1491-2. PubMed ID: 582541
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning.
    Beninger RJ, Hahn BL.
    Science; 1983 Jun 17; 220(4603):1304-6. PubMed ID: 6857251
    [Abstract] [Full Text] [Related]

  • 12. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M, Jurgens A, Lôo H, Olié JP, Amado I.
    Encephale; 2008 Oct 17; 34(5):526-33. PubMed ID: 19068343
    [Abstract] [Full Text] [Related]

  • 13. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J, Ault K, Powchik P.
    Biol Psychiatry; 1997 Sep 15; 42(6):522-3. PubMed ID: 9285089
    [No Abstract] [Full Text] [Related]

  • 14. Dextro-amphetamine diminishes negative symptoms in schizophrenia.
    van Kammen DP, Boronow JJ.
    Int Clin Psychopharmacol; 1988 Apr 15; 3(2):111-21. PubMed ID: 3294284
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of pimozide on CSF norepinephrine in schizophrenia.
    Sternberg DE, van Kammen DP, Lake CR, Ballenger JC, Marder SR, Bunney WE.
    Am J Psychiatry; 1981 Aug 15; 138(8):1045-50. PubMed ID: 7258379
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.